STOK Stoke Therapeutics, Inc.: institutional ownership and insider trading
203 funds reported holding $2.70B of Stoke Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $151M, with 27 new positions and 28 funds selling out; over the last 12 months insiders bought $0 and sold $8.94M on the open market; over its last four quarters it reported revenue of $27.6M and net income of −$208M.
STOK revenue and earnings
- Quarter ended Jun 30, 2026: revenue $9.33M, net income −$61.6M, EPS -0.93
- Quarter ended Mar 31, 2026: revenue $6.23M, net income −$50.0M, EPS -0.79
- Quarter ended Dec 31, 2025: revenue $1.40M, net income −$57.9M, EPS -0.97
- Quarter ended Sep 30, 2025: revenue $10.6M, net income −$38.3M, EPS -0.65
Famous investors holding STOK
- Ken Griffin (Citadel Advisors): $16.3M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $8.54M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.04M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.89M, 0.0% of the portfolio
Largest institutional holders of STOK
- BlackRock, Inc. (BLK) — $192M
- RTW INVESTMENTS, LP — $184M
- FMR LLC — $174M
- Lynx1 Capital Management LP — $132M
- Redmile Group, LLC — $129M
- WELLINGTON MANAGEMENT GROUP LLP — $115M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $113M
- BAKER BROS. ADVISORS LP — $109M
- TORONTO DOMINION BANK (TD, TDBCP) — $104M
- VANGUARD GROUP INC — $100.0M
Recent STOK insider trades
- Oct 2, 2026: Allan Jonathan sold 627 shares ($16.5K)
- Oct 1, 2026: Ticho Barry sold 1,051 shares ($27.5K)
- Sep 1, 2026: Ticho Barry sold 5,545 shares ($170K)
- Aug 18, 2026: Kaye Edward M. MD sold 12,567 shares ($403K)
5%+ owners
- RTW Investments, LP: 9.9% (Schedule 13G/A, filed May 15, 2026)
- FMR LLC: 8.5% (Schedule 13G/A, filed Aug 6, 2026)
- Redmile Group, LLC: 6.7% (Schedule 13G/A, filed May 15, 2026)
- Lynx1 Capital Management LP: 6.5% (Schedule 13G/A, filed Aug 14, 2026)
- BVF PARTNERS L P/IL: 5.6% (Schedule 13G, filed Sep 30, 2026)
- Wellington Management Group LLP: 5.2% (Schedule 13G, filed May 15, 2026)
Who owns the most STOK stock?
The largest institutional holders of Stoke Therapeutics, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($192M), RTW INVESTMENTS, LP ($184M), FMR LLC ($174M).
Are insiders buying or selling STOK?
Over the last 12 months insiders bought $0 and sold $8.94M of Stoke Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own STOK?
Ken Griffin, Izzy Englander, Two Sigma, D. E. Shaw.
What was STOK's revenue last quarter?
Stoke Therapeutics, Inc. reported revenue of $9.33M for the quarter ended June 30, 2026, with net income of −$61.6M.
Which ETFs hold STOK?
24 ETFs and mutual funds hold it among their top 100 positions, including VGHAX, XBI, FBIOX, FHCLX.